Navigation Links
US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream
Date:1/6/2009

COMMACK, N.Y., Jan. 6 /PRNewswire/ -- In recent controlled studies conducted by Dr. Richard Bloomer, University of Memphis, scientists found that the patented ingredient in Glyc'n Go(TM), GlycoCarn(R), is the first and only proven ingredient to increase levels of nitric oxide (NO) in the body; thereby increasing blood nitrate/nitrate (NOx) in human subjects.

Nitric oxide acts as a vasodilator and enables an increase in blood flow to the skeletal muscles. This is significant to 1.) increasing oxygen and nutrient delivery for cellular energy production and 2.) removing metabolic wastes such as lactic acid and carbon dioxide. The resulting affect of an NO increase is improved performance and recovery.

Glyc'n Go(TM) is formulated in the USA by LIFEXPAND(TM). The sports supplement assists in shuttling fatty acids into the cell's mitochondria, enhancing ATP energy production. In addition to the NO and energy benefits; Glyc'n Go(TM) provides antioxidant functions by diminishing the potentially harmful effects of free radicals and aiding in the reduction of muscle tissue damage due to lactic acid build up.

Glyc'n Go(TM) delivers more pure GlycoCarn(R) per serving than any other GPLC tablet or capsule on the market today. Glyc'n Go(TM) is the only chewable form of GlycoCarn(R) and has been proven to dissolve 26% faster than tablets, enabling the product to enter the blood stream and take effect with maximum efficiency.

Glyc'n Go(TM) addresses the needs of many athletes, from strength and power, to endurance and speed. The multitude of benefits offer a number of uses to the active human body.

Glyc'n Go(TM) is manufactured in the USA by LIFEXPAND(TM), Inc. As a service and commitment to the athletic community, LIFEXPAND(TM) rigorously tests it products, including Glyc'n Go(TM), under strict protocols. Glyc'n Go(TM) is certified banned-substance free by Informed-Choice(TM) and HFL, the world's largest sports regulatory and research lab.

Glyc'n Go(TM) is available from leading supplement retailers in 60 count and 16-count individual serving packets. For more detailed information visit www.glycngo.com or call toll free 1-877-GLYCNGO.

Hi resolution photos and images are available at http://www.creativeimage.com/glycngopress


'/>"/>
SOURCE LIFEXPAND
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation
2. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
3. Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor
4. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
5. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
6. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
7. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
8. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
9. Aida Announces Completion of Anti-Cancer Drug Phase Two Testing
10. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
11. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
Breaking Medicine News(10 mins):